Paget’s disease is a term that encompasses several distinct medical conditions, each named after the 19th-century British surgeon and pathologist Sir James Paget. While most medical discussions regarding this term focus on Paget’s disease of bone (osteitis deformans), it is also used to describe specific, rare forms of cancer affecting the skin of the breast (Mammary Paget’s disease) or other areas of the body (Extramammary Paget’s disease).

The primary form, Paget’s disease of bone, is a chronic disorder that interferes with the body’s normal bone remodeling process. In a healthy skeletal system, bone tissue is constantly broken down and replaced. In patients with this condition, the process becomes hyperactive and disorganized, resulting in bone that is structurally abnormal, enlarged, and prone to fractures.

The Nature of Bone Remodeling in Paget’s Disease

To understand the pathology of Paget’s disease of bone, one must first look at the cellular level of skeletal maintenance. Bone is a living tissue that undergoes a continuous cycle of resorption and formation. Two primary cell types drive this process: osteoclasts, which break down old bone, and osteoblasts, which lay down new mineralized tissue.

In Paget’s disease, the osteoclasts become larger and more numerous, resorbing bone at up to nine times the normal rate. In a frantic attempt to keep pace, the osteoblasts rapidly produce new bone. However, because this production is rushed, the new bone is not laid down in the strong, organized "lamellar" pattern characteristic of healthy skeletons. Instead, it takes on a "woven" or "mosaic" structure. This woven bone is bulkier but significantly weaker and more vascular than healthy bone, leading to the deformities and complications associated with the disease.

Epidemiology and Risk Factors

Paget’s disease of bone is the second most common bone remodeling disorder, following osteoporosis. It is rarely diagnosed in individuals under the age of 40 and becomes increasingly prevalent with advancing age. Statistics suggest that it affects approximately 1% to 2% of the population over age 55 in certain regions.

There is a distinct geographic distribution to the disease. It is most common in individuals of European descent, particularly those in the United Kingdom, Western Europe, and countries settled by European immigrants, such as Australia, New Zealand, and North America. Conversely, the disease is rare in East Asia, Scandinavia, and parts of Africa.

While the exact cause remains a subject of ongoing research, two primary factors have emerged:

  1. Genetics: Family history plays a significant role. Mutations in the SQSTM1 gene, which codes for a protein involved in osteoclast function, are found in many patients. Up to 40% of patients with a strong family history of the disease carry this mutation.
  2. Environmental Triggers: The "slow virus" theory suggests that a viral infection (possibly a paramyxovirus like measles) contracted early in life may trigger the disease decades later in genetically susceptible individuals. However, as measles vaccination rates have increased, the incidence and severity of Paget’s disease have declined, lending weight to this hypothesis.

Identifying the Symptoms of Paget’s Disease of Bone

A defining characteristic of Paget’s disease is that it is often asymptomatic. Many patients only discover they have the condition when an X-ray or a routine blood test—showing elevated alkaline phosphatase—is performed for an unrelated reason. When symptoms do manifest, they vary depending on which bones are affected.

Bone and Joint Pain

Pain is the most frequent complaint. It is often described as a deep, dull ache that may worsen at night or during rest. Unlike the pain of osteoarthritis, which usually improves with rest, Pagetoid pain can be persistent. If the disease is located near a joint, it can cause secondary arthritis by altering the alignment of the bones, leading to increased wear and tear on the cartilage.

Visible Deformities and Structural Changes

As the disease progresses, the affected bones may enlarge and bow.

  • The Legs: The femur (thigh bone) or tibia (shin bone) may bow outward, leading to a "bow-legged" appearance. This change can affect a person's gait and put secondary stress on the hips and ankles.
  • The Skull: Enlargement of the skull is a classic clinical sign. Patients may notice that their hat size has increased. In more severe cases, the thickening of the skull can lead to headaches and a feeling of heaviness.
  • The Spine: If the vertebrae are involved, the spine may curve (kyphosis), and the patient may experience a loss of height.

Neurological Complications

Because Pagetoid bone is larger than normal, it can compress nearby nerves.

  • Hearing Loss: This occurs when the disease affects the skull or the temporal bone, compressing the auditory nerve or affecting the small bones of the middle ear (ossicles).
  • Cranial Nerve Palsy: Pressure on nerves exiting the skull can lead to vision issues or facial numbness.
  • Spinal Stenosis: In the spine, enlarged vertebrae can narrow the spinal canal, leading to tingling, numbness, or weakness in the limbs.

Diagnostic Procedures and Imaging

A definitive diagnosis of Paget’s disease of bone typically requires a combination of laboratory tests and medical imaging.

Serum Alkaline Phosphatase (ALP)

Osteoblasts release an enzyme called alkaline phosphatase into the bloodstream during bone formation. Because bone turnover is so high in Paget’s disease, ALP levels are often significantly elevated. This is a primary tool for both diagnosis and monitoring the effectiveness of treatment.

Radiography (X-rays)

X-rays are the gold standard for identifying the structural changes of Paget’s disease. Radiologists look for specific markers:

  • Bone Enlargement: The bone appears thicker than surrounding healthy bone.
  • Cortical Thickening: The outer layer of the bone becomes denser.
  • "Cotton Wool" Appearance: In the skull, the mix of lytic (bone loss) and sclerotic (bone gain) areas creates a patchy, tufted appearance.
  • Lytic Wedges: In the long bones of the legs, an advancing "v-shaped" area of bone resorption may be visible.

Bone Scintigraphy (Bone Scan)

A bone scan involves injecting a small amount of radioactive tracer that travels to areas of high bone turnover. This is the most sensitive way to determine the extent of the disease throughout the skeleton, as it highlights all affected sites at once.

Rare and Severe Complications

While most cases are manageable, Paget’s disease can lead to life-threatening complications if left untreated or if it reaches an advanced stage.

Pagetoid Sarcoma

The most feared complication is the malignant transformation of the bone, known as Pagetoid sarcoma (osteosarcoma). This occurs in less than 1% of patients but is highly aggressive. It should be suspected if a patient with stable Paget’s disease experiences a sudden, dramatic increase in pain or a new swelling at a previously affected site.

High-Output Heart Failure

In cases where the disease is extensive (affecting more than 35% of the skeleton), the increased vascularity of the Pagetoid bone acts like a series of small shunts. The heart must pump much harder to maintain circulation to these hyper-vascularized bones, which can eventually lead to heart failure.

Hypercalcemia and Kidney Stones

While blood calcium levels are usually normal in Paget’s disease patients, prolonged immobilization (for instance, following a fracture) can cause calcium to leach out of the bones and into the blood, leading to hypercalcemia, constipation, and kidney stones.

Mammary Paget’s Disease: A Distinct Entity

It is crucial to distinguish the bone condition from Mammary Paget’s disease. This is a rare form of breast cancer that manifests on the skin of the nipple and areola.

Symptoms and Misdiagnosis

Mammary Paget’s disease is frequently misdiagnosed as eczema or dermatitis because its early symptoms include redness, scaling, itching, and minor crusting. However, unlike eczema, it typically affects only one breast and does not respond to topical steroids. As the condition progresses, it may cause nipple discharge or an inverted nipple.

The Underlying Cancer

In the vast majority of cases, Mammary Paget’s disease is a sign of an underlying breast cancer—either ductal carcinoma in situ (DCIS) or invasive ductal carcinoma. The "Paget cells" found in the skin are actually cancer cells that have migrated from the milk ducts to the surface of the nipple. Diagnosis requires a skin biopsy, and treatment generally follows standard breast cancer protocols, including surgery and radiation.

Extramammary Paget’s Disease (EMPD)

Extramammary Paget’s disease is an even rarer condition. It is a slow-growing skin cancer that occurs in areas rich in apocrine sweat glands, most commonly the vulva, perianal region, or scrotum.

EMPD presents as a chronic, itchy, red, or white plaque-like lesion. Because it looks like a simple fungal infection or dermatitis, it often goes undiagnosed for years. While EMPD can be confined to the skin (primary), it is sometimes associated with an internal malignancy (secondary), such as colorectal or bladder cancer. Treatment usually involves wide local excision (surgery) or Mohs micrographic surgery.

Current Treatment Strategies for Paget’s Disease of Bone

Not every patient with Paget’s disease of bone requires medication. If the disease is asymptomatic and located in a bone that is not weight-bearing or near a major joint, a "watch and wait" approach may be taken. However, treatment is recommended if the patient is symptomatic or if the disease is active in the skull, spine, or weight-bearing long bones.

Bisphosphonates

Bisphosphonates are the cornerstone of modern treatment. These drugs bind to the bone surface and inhibit the activity of osteoclasts, effectively slowing down the abnormal remodeling cycle.

  • Zoledronic Acid (Reclast/Zometa): Usually administered as a single intravenous infusion, this is currently the most effective treatment, often leading to remission that lasts for several years.
  • Oral Bisphosphonates (Alendronate, Risedronate): These are taken as pills, typically daily or weekly. They require strict adherence to dosing instructions (taking them on an empty stomach with a full glass of water and remaining upright for 30 minutes) to avoid esophageal irritation.

Calcitonin

Calcitonin is a naturally occurring hormone that regulates calcium levels. While it can inhibit bone resorption, it is less effective than bisphosphonates and is generally reserved for patients who cannot tolerate other medications. It is administered via injection or nasal spray.

Surgical Intervention

Surgery may be necessary to address the structural damage caused by the disease. This includes:

  • Joint Replacement: Particularly of the hip or knee, if severe arthritis has developed.
  • Osteotomy: Cutting and realigning a bowed bone to improve weight distribution.
  • Fracture Repair: Pagetoid bone can be "chalk-like" and brittle, requiring specialized hardware (rods or plates) for stabilization during healing.

Lifestyle Management and Support

Living with Paget’s disease involves more than just pharmacological intervention. Diet and exercise play a supportive role in maintaining skeletal health.

Nutrition: Calcium and Vitamin D

Because bisphosphonates work by shifting bone metabolism, the body needs an adequate supply of calcium and vitamin D to build healthy bone. Patients are often advised to take supplements, especially after receiving an infusion of zoledronic acid, to prevent a temporary drop in blood calcium levels.

Physical Therapy

Exercise helps maintain joint mobility and muscle strength, which can compensate for weakened bones. However, because Pagetoid bone is more susceptible to stress fractures, high-impact activities should be avoided. A physical therapist can design a low-impact program focusing on walking, swimming, or stationary cycling.

Use of Assistive Devices

For those with significant bowing of the legs or balance issues, using a cane or walker can prevent falls and subsequent fractures. Orthopedic shoes or heel lifts can also help if the disease has caused one leg to become shorter than the other.

Summary: Key Takeaways on Paget’s Disease

Paget’s disease is a complex condition that requires careful differentiation between its skeletal and dermatological forms.

  • Paget’s disease of bone is a metabolic disorder of bone remodeling, characterized by high bone turnover and structural weakness. It is often discovered through elevated ALP levels or characteristic X-ray patterns.
  • Mammary and Extramammary Paget’s disease are rare forms of cancer affecting the skin and require entirely different oncological treatments.
  • Management of the bone condition has been revolutionized by bisphosphonates, which can put the disease into long-term remission and prevent serious complications like hearing loss or heart failure.
  • Early Detection is key. While many live symptom-free, monitoring the disease in its early stages can prevent the permanent deformities and neurological damage that occur when the bone is allowed to enlarge unchecked.

Frequently Asked Questions (FAQ)

What is the first sign of Paget’s disease of bone?

For many, there is no first sign. However, when symptoms do appear, the most common is a persistent, dull ache in the affected bone or a joint. In some cases, a patient might notice a change in the shape of a bone or a sudden increase in hat size.

Is Paget’s disease of bone a form of cancer?

No. Paget’s disease of bone is a chronic metabolic disorder. While it carries a very small risk (less than 1%) of turning into a bone cancer called sarcoma, the disease itself is non-malignant.

Can Paget’s disease be cured?

There is no permanent cure that removes the underlying genetic susceptibility, but modern treatments like zoledronic acid can put the disease into complete remission for years, effectively stopping its progression and preventing symptoms.

Is Paget’s disease of bone hereditary?

There is a strong genetic component. If you have a first-degree relative (parent or sibling) with the disease, your risk of developing it is significantly higher. Genetic testing for the SQSTM1 mutation is possible but is usually only done in a research context or for specific familial cases.

Can children get Paget’s disease?

Paget’s disease of bone is almost exclusively an adult condition, typically appearing after age 40. There is an extremely rare genetic condition called Juvenile Paget’s disease that affects children, but it is a distinct and much more severe disorder.